InvAscent

InvAscent is an investment advisory firm established in 2006 and based in Mauritius, with a focus on the Indian market. It manages several funds, including EILSF, India Life Sciences Fund II, and India Life Sciences Fund III, which provide private equity growth capital to small and mid-sized companies in the pharmaceutical, healthcare, animal health, and medical technology sectors. The firm typically invests between USD 10 million and USD 40 million for significant minority stakes, supporting clients in capacity expansion, product development, and acquisitions. By targeting early-stage opportunities, InvAscent aims to foster growth within these critical industries in India.

Hari Buggana

Co-Founder, Managing Director & Chairman

Vishy Chebrol

Co-Founder, Chief Investment Officer and Managing Director

Anurag Dhingra

Vice President

Nithya Govind

Vice President, Investments

Gauri Gupta

Private Equity Associate

Sumit Gupta

Managing Director

Jeevak Gupta

Vice President, Private Equity

Priyanka Sawant

Senior Associate, Private Equity

12 past transactions

Accumax

Private Equity Round in 2022
Accumax is a manufacturer of liquid handling products and lab consumables, primarily serving the clinical, biotechnology, molecular biology, life science, pharmaceutical, and biopharmaceutical sectors. The company offers a diverse range of products, including pipettes, dispensers, controllers, pipette tips, centrifuge tubes, PCR consumables, and deep well plates. Accumax focuses on delivering precision and ease of use in laboratory settings, ensuring that researchers have reliable tools to support their work.

Malladi Drugs

Private Equity Round in 2022
Malladi Drugs and Pharmaceuticals Limited is a pharmaceutical company based in Chennai, India, founded in 1980. It specializes in the manufacture of active pharmaceutical ingredients across various therapeutic segments, including cough and cold, anti-histamines, anti-convulsants, anti-depressants, and anxiolytics. The company also produces intermediates, specialty products, chiral building blocks, and specialty chemicals. In addition to its manufacturing capabilities, Malladi Drugs offers contract manufacturing, custom synthesis, and contract research services. The company markets and sells its products both in India and internationally, and it operates a manufacturing facility in Carlstadt, New Jersey.

MediBuddy

Series B in 2021
MediBuddy is the award-winning technology platform from Medi Assist that transforms the health insurance industry at the very core. MediBuddy, with its diverse offerings for various stakeholders of the health benefits industry, makes the process of discovering, accessing, utilizing and monitoring health benefits seamless, real-time and virtually paperless. Here is how MediBuddy addresses the varying needs of the diverse stakeholders in the health benefits ecosystem: • Members: MediBuddy is a comprehensive one-stop health benefits management platform that gives members access to inpatient, outpatient, wellness, fitness and preventive care services offered by our curated network of healthcare providers. Accessible both as an online portal as well as a mobile app, MediBuddy gives members unparalleled, real-time access to all their health benefits anytime and from anywhere. • Corporate HR: Individual logins for HR members provide them a transparent view of everyday claims management. The dashboard gives real-time information about claims in process, settled, denied, etc., and also allows HR members to raise, track or manage claims on behalf of their employees. • Insurers and decision makers: MediBuddy offers near-real-time MIS report of all critical parameters that allows for comparative study across years and policies with ease. Our business analytics module packs the power of multiple pivot tables into simple drop-downs for deep, decisive insights into your portfolio. Simple, graphical representation of data enables easy comparison, trend mapping and predictive analysis. • Hospitals: Medi Assist network hospitals enjoy real-time access to all cashless claims with MediBuddy. From receiving alerts for planned eCashless hospitalization, to raising preauthorization, enhancement and final billing, and also dashboards to view total claims settled, in-process, etc., hospitals get all the information they need on one common interface.

Murli Krishna Pharma

Private Equity Round in 2020
Murli Krishna Pharma Private Limited develops and manufactures pellets, micro-pellets, and granules using aqueous based technology. Its products include azithromycin mups and granules, budesonide nano pellets, budesonide nano solution, clarithromycin mups and granules, dex rabeprazole pellets, dexlansoprazole pellets, diclofenac sodium pellets, domperidone SR pellets, everolimus pellets, and itraconazole pellets. The company was founded in 2004 and is based in Pune, India.

Sharp Sight

Private Equity Round in 2020
Sharp Sight Laser Centre Private Limited operates a chain of eye care clinics in India. It offers eye testing, cataract eye surgery, refractive, retina, glaucoma, cornea, pediatric, and orbit services. The company was founded in 1998 and is based in New Delhi, India.

Intron Life Sciences

Private Equity Round in 2019
Intron Life Sciences Private Limited manufactures probiotic products for poultry and aquaculture industries. The company’s products includes lactomax gold, lactomax, check, rapigrow, sanguard, livorol, ammox, and welgrom for poultries; and ammroid, digimax, pondfresh, ultipro, biomend, biogran, genie, toxoff, soilex, sumo, and realbind for aquaculture companies. It also offers custom-made probiotic products for food industry, poultries, and aquaculture companies. Intron Life Sciences Private Limited was incorporated in 2018 and is headquartered in Hyderabad, India.

Strides Arcolab

Private Equity Round in 2018
Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bangalore, India. The Company has two business verticals, viz., Regulated Markets and Emerging Markets. Strides has a global manufacturing footprint with eight manufacturing facilities spread across four continents, including five US FDA approved facilities and two facilities for the rest of world markets . The Company has a dedicated R&D facility in India with global filing capabilities and a strong footprint across 100 countries.

Oliva Clinic

Series A in 2017
Oliva Clinic is a medico aesthetic clinic that focuses on leveraging ad­vances in medicine to make look more beautiful and youthful.

Stericon Pharma

Private Equity Round in 2016
Stericon Pharma Pvt. Ltd. manufactures sterile multipurpose contact lens cleaning solution and sterile eye and nasal formulations. The company was incorporated in 1990 and is based in Bengaluru, India.

Sandor

Seed Round in 2016
Sandor Medicaids Pvt. Ltd. is a nationwide distribution company specializing in supplies to hospitals and government institutions. It has developed efficient systems and capabilities to supply specialty drugs, device and equipment to hospitals. Since its inception in 1995 in Hyderabad, the company has focused on bringing high-tech biomedical and biotechnology products into India. Sandor has been the first company to bring “Point of Care” concept to the Indian ICU in 1996 by launch of i-stat, a state of the art product for emergency monitoring of patients. The company started as a sales, marketing and distribution company and over time evolved as a nationwide distribution, sales and marketing company by 2008 when Genzyme launched their operations in India. It can today boast of a national level distribution network with 21CFR compliant cold chain facilities covering most of Indian states. Our efficient and compliant 20 branch distribution network supports drug and device manufacturers launch products with ready access to more than 3000 hospitals across India. The company today has more than 180 vendor registrations in Government and private Institutions making it the only partner for foreign or domestic manufacturers to bring their products to hospitals at the most economical costs while maintaining the highest ethical standards. The company has over time developed a strong sales and marketing team which is helping it launch own branded products in select therapeutic area like Critical Care, Nephrology and Transplantation and Pain Management. Our strong presence in Government Institutions has ensured direct sales to all users without help of any sub dealer or liaison agents. The company also provides complete regulatory support to partners and has in-house pharmacovigilance function besides having a strong custom clearing department. A firm foothold in the Indian Hospital procurement system has made Sandor a partner of choice for any new launch of medical drugs, devices and equipment in the Indian Hospital System.

Oliva Clinic

Series A in 2014
Oliva Clinic is a medico aesthetic clinic that focuses on leveraging ad­vances in medicine to make look more beautiful and youthful.